Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hereditary Gastric Cancer Syndromes: An Integrated Genomic and Clinicopathologic Study of the Predisposition to Gastric Cancer

NCT03030404 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT03030404
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03030404 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hereditary Gastric Cancer Syndromes: An Integrated Genomic and Clinicopathologic Study of the Predisposition to Gastric Cancer
Lead sponsor
National Cancer Institute (NCI)
Phase
Observational
Overall status
Completed
Start date
January 27, 2017
Completion date
March 31, 2025
Enrollment
733 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

familial diffuse gastric cancer, gastric adenocarcinoma and proximal polyposis of the stomach (gapps), hereditary diffuse gastric cancer (hdgc), stomach cancer, stomach neoplasms